CD47 and neoplasm: In another elegant study, Chowdhury et al. (2019) achieved increased activation of tumour-infiltrating T cells in vivo using different tumour models by transforming a non-pathogenic E. coli strain with a targeting molecule against CD47 (Chowdhury et al., 2019).